A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer
Although toxin may have some advantages compared to chemotherapeutic drugs in cancer therapy, e.g. a potent cytotoxic activity and a reduced risk of resistance, their successful application in the treatments to solid tumors still remains to be fully demonstrated. In this study, we genetically modifi...
Main Authors: | Stefania Zuppone, Chiara Assalini, Claudia Minici, Oronza A. Botrugno, Flavio Curnis, Massimo Degano, Angelo Corti, Francesco Montorsi, Andrea Salonia, Riccardo Vago |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.846958/full |
Similar Items
-
High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin
by: Massimo Bortolotti, et al.
Published: (2016-06-01) -
Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions)
by: Maria Serena Fabbrini, et al.
Published: (2017-10-01) -
Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells
by: Lucia Salvioni, et al.
Published: (2022-07-01) -
Saporin-S6: A Useful Tool in Cancer Therapy
by: Letizia Polito, et al.
Published: (2013-10-01) -
Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells
by: Letizia Polito, et al.
Published: (2017-05-01)